This model was utilized in order to evaluate the effects of D and D + T on the NSCLC tumor microenvironment and more specifically, on the immune cell component of the TME, as the ex vivo system with low-dose IL-2 is optimal for promoting immune cell survival compared with other cells present in the TME. The gene discussed is IL2; the disease is non-small cell lung carcinoma.